Novo CEO pressed by Senate to cut costs of weight problems, diabetic issues medication CEO Lars Fruergaard Jørgensen instructed lawmakers the business would take into consideration new talks with insurers with regard to the listing rates of Wegovy and copyright should they pledge to help keep the medicines on their https://kethek.com/